{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "14529406",
  "DateCompleted": {
    "Year": "2004",
    "Month": "03",
    "Day": "19"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "07",
    "Day": "28"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "1381-6128",
      "JournalIssue": {
        "Volume": "9",
        "Issue": "27",
        "PubDate": {
          "Year": "2003"
        }
      },
      "Title": "Current pharmaceutical design",
      "ISOAbbreviation": "Curr Pharm Des"
    },
    "ArticleTitle": "Cyclooxygenase-2 inhibition and gastric cancer.",
    "Pagination": {
      "StartPage": "2281",
      "EndPage": "2288",
      "MedlinePgn": "2281-8"
    },
    "Abstract": {
      "AbstractText": [
        "Epidemiological evidences suggest that chronic use of aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs) might be associated with a reduced risk of gastrointestinal cancers, including gastric cancer. The pre-cancerous gastric lesions and gastric cancers over-expressed cyclooxygenase (COX)-2. This overexpression not only is associated with Helicobacter pylori infection, but also maybe due to exposure to carcinogens. Targeted inhibition of COX, especially the COX-2 isoform, can lead to growth inhibition and apoptosis of gastric cancer in vitro. Various mechanisms, including COX-dependent and COX-independent pathways, have been identified and will be discussed in this article. Animal xenograft models have confirmed the tumor suppressing effects of COX-2 inhibitors. Human studies are underway to examine the use of COX-2 inhibitor in the treatment of pre-cancerous lesions. COX-2 inhibitors have a promising role in the prevention and treatment of gastric cancer."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Medicine, University of Hong Kong, Hong Kong. bcywong@hku.hk"
          }
        ],
        "LastName": "Jiang",
        "ForeName": "Xiao Hua",
        "Initials": "XH"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Wong",
        "ForeName": "Benjamin C Y",
        "Initials": "BC"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United Arab Emirates",
    "MedlineTA": "Curr Pharm Des",
    "NlmUniqueID": "9602487",
    "ISSNLinking": "1381-6128"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Cyclooxygenase 2 Inhibitors"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Cyclooxygenase Inhibitors"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Isoenzymes"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Membrane Proteins"
    },
    {
      "RegistryNumber": "EC 1.14.99.1",
      "NameOfSubstance": "Cyclooxygenase 2"
    },
    {
      "RegistryNumber": "EC 1.14.99.1",
      "NameOfSubstance": "PTGS2 protein, human"
    },
    {
      "RegistryNumber": "EC 1.14.99.1",
      "NameOfSubstance": "Prostaglandin-Endoperoxide Synthases"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "statistics & numerical data"
      ],
      "DescriptorName": "Clinical Trials as Topic"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cyclooxygenase 2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cyclooxygenase 2 Inhibitors"
    },
    {
      "QualifierName": [
        "pharmacology",
        "therapeutic use"
      ],
      "DescriptorName": "Cyclooxygenase Inhibitors"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "antagonists & inhibitors",
        "metabolism"
      ],
      "DescriptorName": "Isoenzymes"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Membrane Proteins"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Prostaglandin-Endoperoxide Synthases"
    },
    {
      "QualifierName": [
        "drug therapy",
        "enzymology"
      ],
      "DescriptorName": "Stomach Neoplasms"
    }
  ],
  "NumberOfReferences": "108"
}